An advisory committee to the Food and Drug Administration voted 18 to 4, with one abstention, that the benefits of the drug, lorcaserin, outweighed the risks. If the FDA approves the drug by its scheduled deadline of June 27, lorcaserin would be the …
See all stories on this topic »
We LOVE you so.. how about liking us on Facebook?..
Powered By Facebook Like Post Plugin